| P2093 | author name string | S Gandy | |
| | S Petanceska | |
| P2860 | cites work | Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 |
| | Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors | Q24294213 |
| | Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease | Q24316501 |
| | A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells | Q28119154 |
| | Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid | Q28279517 |
| | Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease | Q29614374 |
| | Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides | Q32067582 |
| | Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. | Q33642350 |
| | Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation | Q33731523 |
| | Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo | Q34063772 |
| | Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor | Q34475374 |
| | Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats | Q34564472 |
| | Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities | Q36061994 |
| | Activated release of membrane-anchored TGF-alpha in the absence of cytosol | Q36232614 |
| | Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide | Q36578141 |
| | Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein. | Q36749952 |
| | Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein | Q36935627 |
| | Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor | Q37265547 |
| | Processing of Alzheimer A beta-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease | Q40569985 |
| | M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update | Q40983072 |
| | Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line. | Q41136817 |
| | Regulated cleavage of Alzheimer beta-amyloid precursor protein in the absence of the cytoplasmic tail | Q41509927 |
| | The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling | Q42462551 |
| | Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. | Q42476656 |
| | Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells. | Q42515703 |
| | Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation | Q43705003 |
| | Estrogen therapy in postmenopausal women: effects on cognitive function and dementia | Q46765861 |
| | Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. | Q46833795 |
| | Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). | Q48092766 |
| | Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. | Q48477194 |
| | Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. | Q48519738 |
| | Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition | Q48601482 |
| | Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. | Q49122782 |
| | Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. | Q52532656 |
| | Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein. | Q53200160 |
| | Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer's amyloid precursor protein. | Q53214791 |
| | Neuron loss in APP transgenic mice | Q59060085 |
| | Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions | Q70478363 |
| | Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion | Q77499756 |
| | A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro | Q77520422 |
| | An essential role for ectodomain shedding in mammalian development | Q77544828 |
| | Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner | Q77781712 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 44-52 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism | |
| P478 | volume | 1502 | |